Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Acute myeloid leukemia, adult


Other Names for this Disease

  • Acute granulocytic leukemia
  • Acute myelogenous leukemia
  • Acute non-lymphocytic leukemia
  • Adult acute myeloid leukemia
  • AML adult
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Clinical Trials & Research for this Disease

  • The Research Portfolio Online Reporting Tool (RePORT) provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research. Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, click on the link and enter the disease name in the "Terms Search" box. Then click "Submit Query".

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Idarubicin HCl for injection
Trade Name
(Manufacturer Name)
Idamycin®
(Pfizer)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Sargramostim
Trade Name
(Manufacturer Name)
Leukine®
(Genzyme)
Indication
The FDA has approved this product to be used in this manner.
Following induction chemotherapy in older adult patients with acute myelogenous leukemia to shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death.
More Information about this product Drug Information Portal

Generic Name Gemtuzumab zogamicin
Trade Name
(Manufacturer Name)
Mylotarg®
(Wyeth Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for cytotoxic chemotherapy
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Filgrastim
Trade Name
(Manufacturer Name)
Neupogen®
(Amgen, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of adults with acute myeloid leukemia.
More Information about this product Drug Information Portal

Generic Name Mitoxantrone HCl
Trade Name
(Manufacturer Name)
Novantrone® (injection)
((OSI) Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.
More Information about this product Drug Information Portal

Other Names for this Disease
  • Acute granulocytic leukemia
  • Acute myelogenous leukemia
  • Acute non-lymphocytic leukemia
  • Adult acute myeloid leukemia
  • AML adult
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.